BELLICUM PHARMACEUTICXXXPENDING POSSIBLE FUTURE EFF: 03/04/24

Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BELLICUM PHARMACEUTICXXXPENDING POSSIBLE FUTURE EFF: 03/04/24 REORG STOCK, CUSIP 079ESC026.